Literature DB >> 10744362

Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes. Slovak Fungaemia study group.

V Krcméry1, G Kovacicová.   

Abstract

A 10-year prospective survey of fungaemia in the Slovak Republic, involving 31 microbiology laboratories and 71 hospitals, was conducted from 1989-1998 (10 years): 310 fungaemias were analyzed for etiology, clinical characteristics, therapy, and outcome. C. albicans was responsible for 191 (61.6%) fungaemias, non-albicans Candida spp. (NAC) for 97 (31.3%), non-Candida yeasts for 18 (5.8%) and moulds (Fulsarium spp.) for four fungaemias. The most frequent NAC isolated from blood cultures were C. parapsilosis--30 (9.7%), C. krusei--18 (5.8%), C. tropicalis--14 (4.5%), and C. glabrata--10 (3.2%). Secular trends in etiology showed a sustaining decrease of C. albicans (from 100% in 1989 to 50.7% in 1998) and increase of NAC (from 0% in 1989-1990 to 46.3% in 1998). Non-Candida yeasts and moulds showed a stable proportion during the investigated period. There were statistically significant differences in etiology of fungaemia various subgroups of patients: non-albicans Candida spp. was significantly more frequent observed among subgroups of patients with pancreatitis and coma (53.3% vs. 31.3%, p < or = 0.02) and less frequently in the subgroup of neonates (15.0% vs. 31.3%, p < or = 0.006). Vice versa, C. albicans appeared more frequently in neonates (85%).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744362     DOI: 10.1016/s0732-8893(99)00096-6

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  13 in total

1.  Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain.

Authors:  J Pemán; E Cantón; M Gobernado
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

Review 2.  Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients.

Authors:  Ercole Concia; Anna Maria Azzini; Michela Conti
Journal:  Drugs       Date:  2009       Impact factor: 9.546

3.  Candida guilliermondii fungemia in patients with hematologic malignancies.

Authors:  Corrado Girmenia; Giampaolo Pizzarelli; Francesco Cristini; Francesco Barchiesi; Elisabetta Spreghini; Giorgio Scalise; Pietro Martino
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients.

Authors:  Vladimír Hrabovský; Victoria Takáčová; Eva Schréterová; Lydia Pastvová; Zuzana Hrabovská; Katarina Čurová; Leonard Siegfried
Journal:  Folia Microbiol (Praha)       Date:  2017-03-30       Impact factor: 2.099

5.  Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces.

Authors:  D M Kuhn; J Chandra; P K Mukherjee; M A Ghannoum
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Authors:  D M Kuhn; T George; J Chandra; P K Mukherjee; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  A genome sequence survey shows that the pathogenic yeast Candida parapsilosis has a defective MTLa1 allele at its mating type locus.

Authors:  Mary E Logue; Simon Wong; Kenneth H Wolfe; Geraldine Butler
Journal:  Eukaryot Cell       Date:  2005-06

8.  Global trends in candidemia: review of reports from 1995-2005.

Authors:  Juliette Morgan
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

9.  Yeasts isolated from blood and catheter in children from a public hospital of São Paulo, Brazil.

Authors:  F E Matsumoto; R F Gandra; L S Ruiz; M E Auler; S A V Marques; M F C Pires; W Gambale; C R Paula
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

10.  Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea.

Authors:  Jin-Sol Lee; Jong Hee Shin; Kyungwon Lee; Mi-Na Kim; Bo-Moon Shin; Young Uh; Wee-Gyo Lee; Hye Soo Lee; Chulhun L Chang; Soo Hyun Kim; Myung Geun Shin; Soon Pal Suh; Dong Wook Ryang
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.